TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Austco Healthcare Limited ( (AU:AHC) ) has shared an update.
Austco Healthcare Limited announced a significant financial performance for the year ending June 30, 2025, with a revenue increase of over 37% and EBITDA growth exceeding 54%. This growth was driven by both organic operations and strategic acquisitions, including the successful integration of Amentco Enterprise Group Pty Ltd and G&S Technologies Limited. The company funded these acquisitions through operating cash flows, maintaining a strong cash position. The strong performance of Amentco led to a higher-than-expected earn-out payment, impacting statutory net profit but not EBITDA. Austco’s CEO highlighted the transformative nature of FY25, emphasizing the company’s robust contracted revenue and strategic execution, positioning it confidently for FY26.
The most recent analyst rating on (AU:AHC) stock is a Buy with a A$0.45 price target. To see the full list of analyst forecasts on Austco Healthcare Limited stock, see the AU:AHC Stock Forecast page.
More about Austco Healthcare Limited
Austco Healthcare Limited is an international provider of healthcare communication and clinical workflow management solutions. Headquartered in Australia, the company operates subsidiaries in six countries and supports healthcare facilities through a global reseller network, focusing on markets such as health, aged care, and acute care across Australia, New Zealand, Canada, the UK, USA, Asia, and the Middle East.
Average Trading Volume: 170,620
Technical Sentiment Signal: Buy
Current Market Cap: A$127.5M
For detailed information about AHC stock, go to TipRanks’ Stock Analysis page.